A carregar...
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
BACKGROUND: We hypothesized that elevations of plasma Oncostatin M (OSM) would be associated with infliximab nonresponse. METHODS: Plasma OSM was measured in Crohn disease patients pre-infliximab with biochemical response (>50% reduction in fecal calprotectin) as the primary outcome. RESULTS: The...
Na minha lista:
| Publicado no: | Crohns Colitis 360 |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6798793/ https://ncbi.nlm.nih.gov/pubmed/31667468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/crocol/otz026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|